Bladder Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)
Recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Los Angeles, California
  • +33 more
2022-04-07
Apr 7, 2022
N
Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue
Recruiting
  • Bladder Cancer
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-04-07
    Apr 7, 2022
    V
    Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)
    Not yet recruiting
    • Bladder Cancer
    • +5 more
    • Bacillus Calmette-Guerin: Strain Russian BCG-I
    • Bacillus Calmette-Guerin: Strain TICE
    • (no location specified)
    2022-04-07
    Apr 7, 2022
    N
    A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
    Not yet recruiting
    • Urothelial Cancer
    • +4 more
      • Washington, District of Columbia
      • +2 more
      2022-04-07
      Apr 7, 2022
      I
      INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
      Recruiting
      • Ovarian Cancer
      • +10 more
      • West Hollywood, California
      • +26 more
      2022-04-06
      Apr 6, 2022
      N
      Bintrafusp Alfa (M7824) and NHS-IL12 (M9241) Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies
      Recruiting
      • Urothelial Cancer
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      2022-04-07
      Apr 7, 2022
      N
      En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
      Recruiting
      • Bladder Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        2022-04-07
        Apr 7, 2022
        N
        The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation
        Recruiting
        • Bladder Cancer
        • intravesical mitomycin-C 40mg/20ml instillation
        • Goyang, Korea, Republic of
          National Cancer Center
        2022-04-05
        Apr 5, 2022
        C
        A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
        Active, not recruiting
        • Bladder Cancer
          • Los Angeles, California
          • +3 more
          2022-04-05
          Apr 5, 2022
          M
          A Study of Oral Erdafitinib in People With Recurrent Non-Invasive Bladder Cancer
          Recruiting
          • Bladder Cancer
          • +2 more
          • Basking Ridge, New Jersey
          • +6 more
          2022-03-29
          Mar 29, 2022
          G
          Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab
          Recruiting
          • Urothelial Carcinoma
          • +4 more
          • Whittier, California
          • +41 more
          2022-04-05
          Apr 5, 2022
          H
          Detection of FGFR Gene Mutations in the Tumor Tissue and Urine of Patients With Urothelial Carcinoma
          Not yet recruiting
          • Bladder Cancer
          • FGFR test
          • (no location specified)
          2022-04-06
          Apr 6, 2022
          A
          A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
          Recruiting
          • Pancreatic Cancer
          • +7 more
          • Glasgow, United Kingdom
          • +5 more
          2022-04-05
          Apr 5, 2022
          S
          S1011 Standard or Extended Pelvic Lymphadenectomy in Treating Patients Undergoing Surgery for Invasive Bladder Cancer
          Active, not recruiting
          • Bladder Cancer
          • therapeutic conventional surgery
          • +2 more
          • Los Angeles, California
          • +34 more
          2022-04-04
          Apr 4, 2022
          A
          Study of ADCT-301 in Patients With Selected Advanced Solid Tumors
          Recruiting
          • Advanced Solid Tumors With Literature Evidence of CD25(+) Treg Content
          • +12 more
          • Palo Alto, California
          • +9 more
          2022-03-24
          Mar 24, 2022
          S
          Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
          Not yet recruiting
          • Small Cell Neuroendocrine Carcinoma of Bladder
          • +2 more
          • Washington, District of Columbia
          • +1 more
          2022-03-28
          Mar 28, 2022
          D
          18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
          Recruiting
          • Bladder Cancer
          • Urothelial Carcinoma
          • Boston, Massachusetts
            Dana Farber Cancer Institute
          2022-04-04
          Apr 4, 2022
          S
          A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer
          Recruiting
          • Non-small Cell Lung Cancer
          • +11 more
          • Birmingham, Alabama
          • +26 more
          2022-04-01
          Apr 1, 2022
          I
          Study of Combined VisioCyt Test and FGFR3 Mutations on a Urinary Sample to Diagnose Bladder Tumors
          Recruiting
          • Bladder Cancer
          • Urine collection (150ml)
          • Blood sample (20 ml)
          • Vandœuvre-lès-Nancy, France
            Institut de Cancérologie de Lorraine
          2022-03-23
          Mar 23, 2022
          I
          Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)
          Active, not recruiting
          • Bladder Cancer
          • +3 more
          • IPI-549 (eganelisib)
          • +2 more
          • Fort Wayne, Indiana
          • +28 more
          2022-04-01
          Apr 1, 2022
          G
          My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors
          Active, not recruiting
          • Neoplasms
          • +4 more
          • Goodyear, Arizona
          • +60 more
          2022-04-01
          Apr 1, 2022
          M
          Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
          Recruiting
          • Breast Cancer
          • +6 more
          • PCR/PCR/LDR Strategy
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          2022-04-01
          Apr 1, 2022
          A
          A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies - 2021
          Completed
          • Non-small Cell Lung Cancer
          • +11 more
          • Scottsdale, Arizona
          • +14 more
          2022-03-31
          Mar 31, 2022
          P
          PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
          Recruiting
          • Bladder Cancer
          • New York, New York
          • +1 more
          2022-03-21
          Mar 21, 2022
          N
          Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
          Recruiting
          • Malignant Neoplasms
          • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            2022-03-31
            Mar 31, 2022